European Heart Journal Advance Access published online on November 30, 2004
European Heart Journal, doi:10.1093/eurheartj/ehi055
Copyright © 2004 by the European Society of Cardiology.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA
* To whom correspondence should be addressed.
Editorial
Obesity and heart failure prognosis: paradox or reverse epidemiology?
Carl J. Lavie, E-mail: clavie{at}ochsner.org
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Guder, S. Frantz, J. Bauersachs, B. Allolio, C. Wanner, M. T. Koller, G. Ertl, C. E. Angermann, and S. Stork Reverse Epidemiology in Systolic and Nonsystolic Heart Failure: Cumulative Prognostic Benefit of Classical Cardiovascular Risk Factors Circ Heart Fail, November 1, 2009; 2(6): 563 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Strandberg, A. Y. Strandberg, V. V. Salomaa, K. H. Pitkala, R. S. Tilvis, J. Sirola, and T. A. Miettinen Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men Eur. Heart J., July 2, 2009; 30(14): 1720 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Lavie, R. V. Milani, and H. O. Ventura Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol., May 26, 2009; 53(21): 1925 - 1932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Lavie, H. O. Ventura, and R. V. Milani The "Obesity Paradox": Is Smoking/Lung Disease the Explanation? Chest, November 1, 2008; 134(5): 896 - 898. [Full Text] [PDF]
|
|
|
|
|
|
W. Galal, Y. R. B. M. van Gestel, S. E. Hoeks, D. D. Sin, T. A. Winkel, J. J. Bax, H. Verhagen, A. M. M. Awara, J. Klein, R. T. van Domburg, et al. The Obesity Paradox in Patients With Peripheral Arterial Disease Chest, November 1, 2008; 134(5): 925 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kenchaiah, S. J. Pocock, D. Wang, P. V. Finn, L. A.M. Zornoff, H. Skali, M. A. Pfeffer, S. Yusuf, K. Swedberg, E. L. Michelson, et al. Body Mass Index and Prognosis in Patients With Chronic Heart Failure: Insights From the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program Circulation, August 7, 2007; 116(6): 627 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tsutamoto, T. Tanaka, H. Sakai, C. Ishikawa, M. Fujii, T. Yamamoto, and M. Horie Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure Eur. Heart J., July 2, 2007; 28(14): 1723 - 1730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Lavie, R. V. Milani, H. O. Ventura, and M. R. Mehra Peak Oxygen Consumption and Heart Failure Prognosis in Women J. Am. Coll. Cardiol., January 23, 2007; 49(3): 375 - 375. [Full Text] [PDF]
|
|
|
|
|
|
X. Kang, L. J. Shaw, S. W. Hayes, R. Hachamovitch, A. Abidov, I. Cohen, J. D. Friedman, L. E.J. Thomson, D. Polk, G. Germano, et al. Impact of Body Mass Index on Cardiac Mortality in Patients With Known or Suspected Coronary Artery Disease Undergoing Myocardial Perfusion Single-Photon Emission Computed Tomography J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1418 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ryan Risks and benefits of weight loss: challenges to obesity research Eur. Heart J. Suppl., November 1, 2005; 7(suppl_L): L27 - L31. [Abstract] [Full Text] [PDF]
|
|